Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU7-164P (RNA, U7 small nuclear 164 pseudogene) is a pseudogene related to U7 small nuclear RNA (snRNA), which in its functional form mediates 3'-end processing of replication-dependent histone pre-mRNAs[1][3][7]. As a pseudogene, RNU7-164P does not produce a functional U7 snRNA and is presumed to be non-functional, though in rare cases pseudogenes can contribute to regulatory RNA pools[4]. There is no evidence that this specific pseudogene is transcribed at functional levels, involved in disease, or can serve as a therapeutic target[2][7]. *Note:* Pseudogenes in general are not considered drug targets, receptors, enzymes, or transporters. They usually arise from duplications or reverse transcription events and often carry sequence similarity but lack protein-coding capacity and canonical biochemical function[4][7]. If you seek structured information for the functional form, search for "U7 small nuclear RNA" instead[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 164 pseudogene (RNU7-164P).